栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/08/10 | 2,246 | 2,265 | 2,217 | 2,259 | +43 | +1.9% | 176,400 |
| 2026/08/07 | 2,162 | 2,220 | 2,162 | 2,216 | +31 | +1.4% | 175,700 |
| 2026/08/06 | 2,183 | 2,222 | 2,167 | 2,185 | +12 | +0.6% | 240,600 |
| 2026/08/05 | 2,090 | 2,173 | 2,083 | 2,173 | +109 | +5.3% | 325,300 |
| 2026/08/04 | 2,082 | 2,085 | 2,021 | 2,064 | -20 | -1% | 320,500 |
| 2026/08/03 | 2,146 | 2,152 | 2,076 | 2,084 | -67 | -3.1% | 483,600 |
| 2026/07/31 | 2,411 | 2,411 | 2,151 | 2,151 | -360 | -14.3% | 1,158,900 |
| 2026/07/30 | 2,504 | 2,540 | 2,465 | 2,511 | -4 | -0.2% | 233,200 |
| 2026/07/29 | 2,478 | 2,537 | 2,424 | 2,515 | +53 | +2.2% | 308,600 |
| 2026/07/28 | 2,548 | 2,579 | 2,432 | 2,462 | -78 | -3.1% | 357,700 |
| 2026/07/27 | 2,578 | 2,580 | 2,428 | 2,540 | -40 | -1.6% | 357,600 |
| 2026/07/24 | 2,522 | 2,596 | 2,516 | 2,580 | +40 | +1.6% | 119,000 |
| 2026/07/23 | 2,562 | 2,589 | 2,534 | 2,540 | -22 | -0.9% | 143,400 |
| 2026/07/22 | 2,574 | 2,574 | 2,537 | 2,562 | -14 | -0.5% | 108,400 |
| 2026/07/21 | 2,595 | 2,619 | 2,566 | 2,576 | +31 | +1.2% | 152,900 |
| 2026/07/17 | 2,558 | 2,606 | 2,523 | 2,545 | -13 | -0.5% | 224,000 |
| 2026/07/16 | 2,613 | 2,613 | 2,531 | 2,558 | -55 | -2.1% | 147,600 |
| 2026/07/15 | 2,572 | 2,631 | 2,557 | 2,613 | +62 | +2.4% | 98,200 |
| 2026/07/14 | 2,560 | 2,581 | 2,544 | 2,551 | +10 | +0.4% | 72,200 |
| 2026/07/13 | 2,541 | 2,562 | 2,498 | 2,541 | +9 | +0.4% | 123,100 |
| 2026/07/10 | 2,562 | 2,604 | 2,517 | 2,532 | +2 | +0.1% | 193,500 |
| 2026/07/09 | 2,531 | 2,563 | 2,502 | 2,530 | -16 | -0.6% | 244,200 |
| 2026/07/08 | 2,512 | 2,566 | 2,510 | 2,546 | +16 | +0.6% | 115,900 |
| 2026/07/07 | 2,601 | 2,614 | 2,515 | 2,530 | -82 | -3.1% | 211,000 |
| 2026/07/06 | 2,617 | 2,634 | 2,595 | 2,612 | +9 | +0.3% | 75,400 |
| 2026/07/03 | 2,666 | 2,697 | 2,597 | 2,603 | -21 | -0.8% | 88,900 |
| 2026/07/02 | 2,573 | 2,695 | 2,488 | 2,624 | +69 | +2.7% | 459,300 |
| 2026/07/01 | 2,534 | 2,559 | 2,472 | 2,555 | +9 | +0.4% | 159,400 |
| 2026/06/30 | 2,553 | 2,555 | 2,483 | 2,546 | -7 | -0.3% | 229,600 |
| 2026/06/29 | 2,525 | 2,554 | 2,496 | 2,553 | +28 | +1.1% | 176,900 |
| 2026/06/26 | 2,489 | 2,530 | 2,483 | 2,525 | +36 | +1.4% | 174,200 |
| 2026/06/25 | 2,576 | 2,576 | 2,478 | 2,489 | -37 | -1.5% | 102,000 |
| 2026/06/24 | 2,579 | 2,585 | 2,500 | 2,526 | -22 | -0.9% | 161,400 |
| 2026/06/23 | 2,657 | 2,704 | 2,470 | 2,548 | -118 | -4.4% | 367,100 |
| 2026/06/22 | 2,657 | 2,731 | 2,653 | 2,666 | +32 | +1.2% | 149,700 |
| 2026/06/19 | 2,676 | 2,720 | 2,634 | 2,634 | -36 | -1.3% | 193,300 |
| 2026/06/18 | 2,621 | 2,708 | 2,621 | 2,670 | +41 | +1.6% | 155,000 |
| 2026/06/17 | 2,683 | 2,690 | 2,620 | 2,629 | -30 | -1.1% | 78,200 |
| 2026/06/16 | 2,645 | 2,681 | 2,613 | 2,659 | +1 | ±0% | 161,200 |
| 2026/06/15 | 2,700 | 2,715 | 2,649 | 2,658 | -42 | -1.6% | 115,800 |
| 2026/06/12 | 2,710 | 2,755 | 2,682 | 2,700 | -4 | -0.1% | 120,700 |
| 2026/06/11 | 2,724 | 2,724 | 2,665 | 2,704 | -20 | -0.7% | 116,800 |
| 2026/06/10 | 2,761 | 2,761 | 2,688 | 2,724 | -20 | -0.7% | 131,500 |
| 2026/06/09 | 2,771 | 2,793 | 2,730 | 2,744 | +12 | +0.4% | 201,900 |
| 2026/06/08 | 2,669 | 2,732 | 2,660 | 2,732 | +62 | +2.3% | 230,300 |
| 2026/06/05 | 2,724 | 2,765 | 2,650 | 2,670 | -30 | -1.1% | 99,300 |
| 2026/06/04 | 2,700 | 2,729 | 2,679 | 2,700 | -41 | -1.5% | 124,200 |
| 2026/06/03 | 2,730 | 2,755 | 2,666 | 2,741 | +58 | +2.2% | 194,100 |
| 2026/06/02 | 2,677 | 2,735 | 2,626 | 2,683 | -6 | -0.2% | 248,200 |
| 2026/06/01 | 2,966 | 2,966 | 2,675 | 2,689 | -280 | -9.4% | 379,800 |
51~
100
件表示中 / 7306件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 242,200円 | +0.2% | +2.0% | 2.39% | 38.61倍 | 1.82倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
| 持田薬 | 327,000円 | +7.7% | +11.7% | 2.60% | 11.48倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 200,800円 | +6.6% | +17.7% | 2.49% | 8.85倍 | 0.82倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 90,600円 | - | - | 0.00% | - | 6.17倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 杏林製薬 | 112,200円 | -3.5% | -42.9% | 2.23% | 42.97倍 | 0.46倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム